ArticlemedRxiv : the preprint server for health sciences2026
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical Data.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
17 authors.
Funding
Abstract
Background: In Bangladesh, cholera treatment focuses on acute watery diarrhea in symptomatic cases at health facilities, though asymptomatic infections are common. Understanding the role of asymptomatic infections in transmission is crucial for designing appropriate control strategies in this setting. Methods: We utilized data from household studies conducted in Dhaka, Bangladesh during 2006-2018 where a symptomatic confirmed cholera case and their household contacts were followed for thirty days. Vibriocidal antibodies, bacteriological culture, and symptom histories were collected at multiple times points. We used a hidden Markov model to estimate risk of infection from intra-household and extra-household (i.e., community and environmental) sources and to quantify relative risk of transmission from symptomatic and asymptomatic infected household contacts. Results: Estimated daily risk of intra-household infection from a symptomatic individual to another household member was 2.6% (95% CI: 0.4% - 5.6%) and from an asymptomatic infected individual to another household member was 1.6% (95% CI: 0.2% - 4.5%). We found no significant differences in probability of infection from asymptomatic compared to symptomatic individuals (OR: 0.60; 95% CI: 0.11 - 3.23). We estimated that daily risk of infection from extra-household sources during follow-up was 1.0% (95% CI: 0.7% - 1.4%). Conclusion: Mitigation measures focused solely on treatment of symptomatic cholera cases may be insufficient to prevent transmission in a household. This supports use of interventions that reduce risk of transmission irrespective of symptoms, such as prophylactic antibiotic treatment for household members and/or providing safe water and hygiene kits following a confirmed household or community case.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.